Information | NCP Flanders

Personalised Medicine

This partnership aims to coordinate and promote research in the area of personalised medicine between the EU, EU countries and regions. The Partnership took off end of 2023. The first call for proposals was launched in January 2024.

The European Partnership for Personalised Medicine (EP PerMed) aims to align and promote regional and national priority setting and funding for research and implementation projects in the field of personalised medicine among the EU Member States, regions and beyond.

EP PerMed builds on over 15 years of EU-funded consortia, initiatives & events, but also on a wide range of national & European regional activities and efforts in all areas of the personalised medicine value continuum.

Key figures

Duration: 10 years
Total budget (national / regional plus EC contribution): Approximately 370 Mio. Euro
Partners: More than 50, mainly funding organisations from Europe and beyond

Participation Flanders

Grant Agreement negotiations for EP PerMed are ongoing. It is expected that the following Flemish partner organisations to participate in the Partnership:

Belgium (Flanders)	Government of Flanders – Vlaams Gewest	https://www.vlaanderen.be/
Belgium (Flanders)	Research Foundation – Flanders – Fonds Wetenschappelijk Onderzoek	https://www.fwo.be/en/
Belgium (Flanders)	Flanders innovation & entrepreneurship – Fonds voor Innoveren en Ondernemen	https://www.vlaio.be/en

The main objectives will be

to ensure a faster uptake of research and innovation results into clinical practice, secure Europe's position in state-of-the-art healthcare provision
to facilitate a shift from a ‘one size fits all’ approach towards taking into account individual differences and better utilising the accumulating data to manage health, disease and its predisposition
to contribute towards more sustainable healthcare systems and independence in data intensive healthcare

Results will translate into delivery of better prevention and healthcare services, improved health outcomes for patients and citizens, and increased satisfaction with health systems.

Open & closed calls

A first joint transnational call for proposals under EP PerMed on "Identification or Validation of Targets for Personalised Medicine Approaches (PMTargets)" was launched in January 2024. The deadline for pre-proposals has passed. The result of the call for proposals is not expected before October 2024. First projects are expected to start end of 2024, beginning of 2025.

Information pages for stakeholders in Flanders:

- dedicated VLAIO webpage
- dedicated FWO webpage

You can register to EP PerMed's newsletter to be kept informed about future calls for proposals here.

Timeline & key documents

More information about the Partnership proposal (February 2022)
In April 2023, the Strategic Research & Innovation Agenda for the Personalised Medicine Partnership was published. The SRIA will support a wide range of stakeholders and experts to further develop programs, activities, and research towards personalised medicine and care, as well as prevention.
In October 2023, during the Spanish Presidency conference on Personalised Medicine, a pre-launch ceremony of the partnership took place. The presentation is available here.

PerMed-related initiatives supporting EP PerMed

Within EP PerMed, several earlier European Initiatives are joined under one roof. It will continue the activities of ERA PerMed in funding transnational innovation and research projects. In addition, EP PerMed will closely together with the International Consortium for Personalised Medicine ICPerMed for overarching strategic activities.

'ICPerMed Family' of Coordination and Support Actions:

4 dedicated to the communication & cooperation with
- Latin American & Caribbean countries (EULAC PerMed)
- China (Sino-EU PerMed/IC2PerMed)
- Africa (EU-Africa PerMed)
2 focus/ed on European Regions (R4PerMed/ SAPHIRE)
2 with research connected topics (HEcoPerMed/PERMIT)
1 on Personalised Prevention (PROPHET)

Contact

Commission services: RTD-EP-PERSONALISED-MEDICINE@ec.europa.eu
The Partnership: eppermed@dlr.de

What are partnerships?

Partnerships group the EC and private and/or public partners, to coordinate and streamline the research & innovation initiatives and funding in some selected key domains.

How to use partnerships?

orientation
Partnerships publish strategic documents, e.g. outlining the main research and innovation challenges or key focus points.

networking
Partnerships often organise events, such as info days, brokerage events, etc. Meet potential partners and learn about the nuances that are not visible in the official documents.

ecosystem analysis
Partnerships typically have an advisory board, and publish impact studies of previous actions. These are good sources of information to uncover the main R&D&I players in the domain.

steering the agenda
Partnerships collaborate with the EC on outlining the strategy and the future funding opportunities in their domain, based on input from industry, academia, and other stakeholders.

EITHOS - European Identity Theft Observatory System

The EITHOS project, funded under Horizon Europe Cluster 3 call “Online identity theft is countered”, aims to develop a “European Identity Theft Observatory System” (EITHOS). The system will provide easy access to information and intelligence about previous and current identity theft related trends to empower EU citizens, Law Enforcements Agencies (LEAs), and policy makers to further contribute to the prevention, detection, and investigation of crimes related to online identity theft. The Cyber and Data Security Lab (CDSL), part of the Law, Science, Technology and Society (LSTS) Research Group at Vrije Universiteit Brussel (VUB), is one of the 12 partners in the EITHOS consortium, contributing its vast expertise on legal aspects of data protection, cybersecurity and information security law and policy.

NCP Flanders

Updates

Funding programmes

About NCP Flanders

Content

Tools